- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06156631
Uncontrolled Hypertension Management Among Jordanian Adults (DASH-ExMAMI)
October 19, 2024 updated by: NASIR AS'AD IBRAHIM MATANI, Universiti Sains Malaysia
An Evaluation of Newly Developed Multimodal Health Intervention Among Uncontrolled Hypertensive Jordanian Adults in Primary Health Care Setting
This study will evaluate a newly developed multimodal health intervention including dietary approach to stop hypertension (DASH) diet, exercise (Ex), and medication adherence (MA) using motivational interviewing (MI) counselling (DASH-Ex MAMI) for hypertensive Jordanian adults in primary care settings.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This interventional study specifically aims to:
- Develop a valid multimodal health intervention that includes DASH, exercise, and medication adherence using MI counselling (DASH-ExMAMI) for hypertensive Jordanian adults in primary care settings.
- Evaluate the effectiveness of the DASH-ExMAMI intervention on systolic and diastolic blood pressure in adults with uncontrolled hypertension in Jordan.
- Evaluate the effectiveness of the DASH-ExMAMI intervention on the dietary habits scores in adults with uncontrolled hypertension in Jordan.
- Evaluate the effectiveness of the DASH-ExMAMI intervention on the physical activity scores in adults with uncontrolled hypertension in Jordan.
- Evaluate the effectiveness of the DASH-ExMAMI intervention on medication adherence scores in adults with uncontrolled hypertension in Jordan.
- Evaluate the impact of the DASH-ExMAMI intervention on body mass indices (BMI) and waist circumferences (WC) in adults with uncontrolled hypertension in Jordan
Study Type
Interventional
Enrollment (Actual)
126
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Irbid, Jordan, 21191
- Al Barha Health Center
-
Irbid, Jordan, 21191
- Al Tattweer Al Hadhary Health Center
-
Irbid, Jordan, 21191
- Al Zahrawi Health Center
-
Irbid, Jordan, 21191
- Maruw Health Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Patient's age between ≥ 18 and 65 years old.
- Has had diagnosed with hypertension and has started his or her treatment plan.
- Has uncontrolled hypertension: The average systolic blood pressure reading that is equal to or higher than 130 mmHg and/or diastolic blood pressure that is equal to or higher than 90 mmHg for the last two patients' records available at the health center.
- Has no other comorbidities that contraindicate exercise or restrict DASH diet.
- Written medical authorization (documented in patient's medical record) by the attending primary healthcare physician approving the patient's participation.
Exclusion Criteria:
- Pregnant and postpartum women
- Has severe hypertension (SBP≥ 200 or DBP ≥110). Resting SBP greater than 200mm Hg or DBP greater than 110mm Hg is a relative contraindication to exercise stress testing.
- Has history of cardio-pulmonary, renal, or musculoskeletal comorbidities that contraindicate exercise or DASH diet.
- This research will exclude all clients who are contraindicated to undergo treadmill tests with extra precautions: history of myocardial infarction within six months, angina, cardiac dysrhythmias, symptomatic aortic stenosis, and heart failure, pulmonary embolus, infarction or hypertension, myocarditis or pericarditis, or endocarditis, aortic dissection, history of renal impairment, brittle diabetes mellitus, bronchial asthma, musculoskeletal problems that might worsen by exercise, and mental health problems that interfere with the comprehension of the intervention and its related safety measures. Clients with a history of metabolic disorders and who follow a specific diet restriction will also be excluded such as celiac disease.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Participants receive DASH-ExMAMI intervention.
Jordanian participants who are adults (age between ≥ 18 and 65 years), have had diagnosed with hypertension and has started his or her treatment plan, and have uncontrolled hypertension (The average systolic blood pressure reading that is equal to or higher than 130 mmHg and/or diastolic blood pressure that is equal to or higher than 90 mmHg for the last two patients' records available at the health centre.
|
The DASH-ExMAMI consists of ten counseling and health education sessions that each last from 20 to 60 minutes over 10 weeks.
The DASH domain will address the following subjects: getting started on DASH, making the move to DASH, tips to reduce salt and sodium, and a week with the DASH eating plan.
The Exercise component consists of brisk walking for 30 minutes every day, five days a week.
The medication adherence domain is based on the participant's Hill-Bone Compliance to High Blood Pressure Therapy Scale items and their scores.
All domains of the intervention are stages and processes of change-matched ones and are provided through 10 motivational interviewing and counseling sessions.
Other Names:
|
|
No Intervention: Participants who do not receive DASH-Ex MAMI
Jordanian participants who are adults (age between ≥ 18 and 65 years), have had diagnosed with hypertension and has started his or her treatment plan, and have uncontrolled hypertension (The average systolic blood pressure reading that is equal to or higher than 130 mmHg and/or diastolic blood pressure that is equal to or higher than 90 mmHg for the last two patients' records available at the health centre.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Systolic blood pressure (SBP)
Time Frame: At two points: pre-intervention (baseline) and post-intervention (after 10 weeks)
|
the average measurement of systolic blood pressure in mmHg using valid automated blood pressure apparatus.
|
At two points: pre-intervention (baseline) and post-intervention (after 10 weeks)
|
|
Diastolic blood pressure (DBP)
Time Frame: At two points: pre-intervention (baseline) and post-intervention (after 10 weeks)
|
the average measurement of diastolic blood pressure in mmHg using valid automated blood pressure apparatus.
|
At two points: pre-intervention (baseline) and post-intervention (after 10 weeks)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Dietary habits
Time Frame: At two points: pre-intervention (baseline) and post-intervention (after 10 weeks)
|
The scores obtained by the 'start the conversation- food frequency questionnaire ' STC-FFQ' which quantifies healthy and unhealthy food components consumed by the clients for the last week over a few months and gives a specific score for each component, with the summary score ranging from 0 to 16-the lowest score indicating the healthiest eating pattern.
|
At two points: pre-intervention (baseline) and post-intervention (after 10 weeks)
|
|
Physical activity
Time Frame: At two points: pre-intervention (baseline) and post-intervention (after 10 weeks)
|
The scores obtained by the international physical activity questionnaire -short form IPAQ-SF which inquiries about three distinct types of activity in three domains (leisure time, domestic/gardening, and work and transport-related activity, as well as sitting).
Walking, moderate-intensity activities, and vigorous-intensity activities are the specific types of activity that are assessed; frequency (measured in days per week) and duration (minutes per day) are gathered individually for each specific type of activity.
The higher the score- expressed in Metabolic Equivalent of Task (MET)-min per week, the more intense the physical activity
|
At two points: pre-intervention (baseline) and post-intervention (after 10 weeks)
|
|
Medication adherence
Time Frame: At two points: pre-intervention (baseline) and post-intervention (after 10 weeks)
|
The scores obtained by the Hill-Bone Compliance to High Blood Pressure Therapy Scale (HB-HBP) which evaluates patient behaviors in three key areas of high blood pressure treatment: 1) reduced sodium intake, 2) appointment keeping, and 3) medication taking.
|
At two points: pre-intervention (baseline) and post-intervention (after 10 weeks)
|
|
Body mass index (BMI)
Time Frame: At two points: pre-intervention (baseline) and post-intervention (after 10 weeks)
|
the output measure of dividing participant's weight in kilograms by their height in meters squared, or BMI = weight (in kg)/height2 (in m2).
|
At two points: pre-intervention (baseline) and post-intervention (after 10 weeks)
|
|
Waist circumference (WC)
Time Frame: At two points: pre-intervention (baseline) and post-intervention (after 10 weeks)
|
The value of WC measurement for a participant at the end of normal breaths, horizontally to the floor level, and at the midpoint between the upper of the iliac crest and the lowest palpable rib in the mid axillary line.
|
At two points: pre-intervention (baseline) and post-intervention (after 10 weeks)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 7, 2024
Primary Completion (Actual)
September 5, 2024
Study Completion (Actual)
October 7, 2024
Study Registration Dates
First Submitted
November 19, 2023
First Submitted That Met QC Criteria
November 25, 2023
First Posted (Actual)
December 5, 2023
Study Record Updates
Last Update Posted (Actual)
October 22, 2024
Last Update Submitted That Met QC Criteria
October 19, 2024
Last Verified
October 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NM2991969
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
Franz Rischard, DOAcceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway...Not yet recruitingPulmonary Hypertension | Pulmonary Arterial Hypertension (PAH)United States
-
Abant Izzet Baysal UniversityNot yet recruitingPRIMARY HYPERTENSIONTurkey (Türkiye)
-
SingHealth PolyclinicsNanyang PolytechnicEnrolling by invitationHypertension,EssentialSingapore
-
Hacettepe UniversityBozok UniversityCompletedHypertension | Arterial Hypertension | Systemic HypertensionTurkey (Türkiye)
-
BackBeat Medical IncNot yet recruitingHypertension, Systolic | Hypertension (HTN) | Heart Failure With Preserved Ejection Fraction (HFpEFGeorgia
-
Xuanwu Hospital, BeijingNot yet recruiting
-
Shenzhen Salubris Pharmaceuticals Co., Ltd.Not yet recruiting
-
Instituto de Cardiologia do Rio Grande do SulCompletedHypertension (HTN) | Hypertension ArterialBrazil
Clinical Trials on DASH-ExMAMI
-
Johns Hopkins UniversityNational Institute on Minority Health and Health Disparities (NIMHD)Completed
-
Case Western Reserve UniversityCompleted
-
Johns Hopkins UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedHigh Blood PressureUnited States
-
Texas Tech UniversityAlliance for Potato Research and EducationCompletedType 2 Diabetes | Blood PressureUnited States
-
Duke UniversityCompletedCardiovascular Diseases | Hypertension | Diet Modification | Women's Health | Digital HealthUnited States
-
National Health Research Institutes, TaiwanTaipei Veterans General Hospital, TaiwanUnknown
-
University of MichiganTerminatedDiastolic Heart Failure | Hypertensive Heart DiseaseUnited States
-
Rockefeller UniversityCompleted
-
Duke UniversityAmerican Heart AssociationCompleted
-
Assiut UniversityNot yet recruitingDyslipidemia Associated With Type II Diabetes Mellitus